August 25, 2026 07:09 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court directs Tarun Tejpal to surrender within two weeks | Supreme Court notice to 20 rebel TMC MPs in disqualification plea | ‘Reservation for poor, not caste’: Stir at Delhi’s Jantar Mantar | Dalit woman 'gangrape-murder' shocker in Karnataka: 4 arrested after body found in well | India dismisses Pakistan's 'frustration' over US envoy's J&K remark | Centre denies US visit clearance to Telangana CM Revanth Reddy, says programmes 'not appropriate' | Delhi Police register FIR in pellet gun case after Rahul Gandhi's sit-in | Rahul Gandhi stages dharna at Delhi police station over CJP protest crackdown, targets Amit Shah | CJP school tour turns chaotic in Jaipur: Cars vandalised, stones pelted as Ashutosh Ranka alleges BJP ‘goons’ attack | Vande Mataram row: Kangana Ranaut slams Sharmila Tagore, says ‘come out of Hindu-Muslim mindset’
Tata
Tata is aiming to expand footprint in nutrition sector. Photo: Tata Consumer Products/Facebook

Protinex, Farex, Dexolac under Tata? Massive deal in final stages

| @indiablooms | Dec 08, 2025, at 01:50 pm

Mumbai/IBNS: Tata Consumer Products Ltd (TCPL) is reportedly in advanced negotiations to acquire Danone SA’s nutraceuticals and specialised nutrition portfolio in India, according to a report by Business Today.

The discussions, ongoing for several months, have gained momentum in recent weeks, with both sides said to be close to finalising the valuation terms of the deal.

TCPL — the company behind brands such as Tata Tea, Tata Salt, and Soulfull — has been actively looking to strengthen its presence in India’s rapidly expanding wellness and nutrition segment.

An acquisition of Danone’s nutrition business would position the company to compete directly with multinational giants like Nestlé and Abbott in the premium nutrition space.

Danone’s India portfolio, which includes popular brands such as Farex, Dexolac, and Protinex, is driven largely by its strong foothold in the nutrition category.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.